Your browser doesn't support javascript.
loading
Photocatalyst under visible light irradiation inactivates SARS-CoV-2 on an abiotic surface
Masashi Uema; Kenzo Yonemitsu; Yoshika Momose; Yoshikazu Ishii; Kazuhiro Tateda; Takao Inoue; Hiroshi Asakura.
Affiliation
  • Masashi Uema; National Institute of Health Sciences
  • Kenzo Yonemitsu; National Institute of Health Sciences
  • Yoshika Momose; National Institute of Health Sciences
  • Yoshikazu Ishii; Toho University School of Medicine
  • Kazuhiro Tateda; Toho University School of Medicine
  • Takao Inoue; National Institute of Health Sciences
  • Hiroshi Asakura; National Institute of Health Sciences
Preprint in English | bioRxiv | ID: ppbiorxiv-364364
ABSTRACT
There is a worldwide attempt to develop prevention strategies against SARS-CoV-2 transmission. Here we examined the effectiveness of visible light-responsive photocatalyst RENECAT on the inactivation of SARS-CoV-2 under different temperatures and exposure durations. The viral activation on the photocatalyst-coated glass slides decreased from 5.93{+/-}0.38 logTCID50/ml to 3.05{+/-}0.25 logTCID50/ml after exposure to visible light irradiation for 6h at 20{degrees}C. On the other hand, lighting without the photocatalyst, or the photocatalyst-coat without lighting retained viral stability. Immunoblotting and electron microscopic analyses showed the reduced amounts of spike protein on the viral surface after the photocatalyst treatment. Our data suggest a possible implication of the photocatalyst on the decontamination of the SARS-CoV-2 in indoor environments, thereby preventing indirect viral spread.
License
cc_no
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
...